Compare EPR Properties (EPR) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EPR Properties vs Halozyme Therapeutics Inc. Common Stock — how do they compare? EPR Properties trades at $54.93 (market cap $4.17B), while Halozyme Therapeutics Inc. Common Stock trades at $112.28 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 3× EPR Properties's market cap, and EPR Properties pays a 6.84% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EPR Properties for 46 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| EPR | HALO | |
|---|---|---|
Market Cap | $4.17B | $12.58B |
Volume | 992,716 | 2,179,278 |
Sector | Real Estate | Health |
52-Week High | $64.32 | $115.22 |
52-Week Low | $48.71 | $61.63 |
Typical Hold Time | 46 Days | 1 Days |
Enterprise Value | $7.68B | $14.49B |
Dividend Yield | 6.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EPR Properties trades at $54.49, up 0.76% today, with a bearish technical signal but oversold oscillators suggesting potential reversal. The REIT shows strong profitability with a 37.66% net income margin and a 6.5% dividend yield, though earnings have been mixed with a recent miss in Q1 2026. Analysts maintain a consensus Buy rating with a $65.50 price target, implying significant upside from current levels.
The outlook is cautiously optimistic given the high dividend yield and discounted valuation, but risks include exposure to interest rate sensitivity and tenant performance in its experiential real estate portfolio. Near-term catalysts include the Q3 2026 earnings release on October 28, 2026, which could validate the company's growth trajectory amid a challenging macro environment.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
